MAVORIXAFOR
UNII 0G9LGB5O2W

Substance Identification & Data

This profile provides standardized clinical and technical data for Mavorixafor, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0G9LGB5O2W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 558447-26-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0G9LGB5O2W

CAS Registry Number

558447-26-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MAVORIXAFOR

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

0G9LGB5O2W

The specific atomic composition represented as a molecular structure string.

InChIKey

C21H27N5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WVLHHLRVNDMIAR-IBGZPJMESA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C126660

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11256587

Unique identification number in the NCBI database of chemical substances.

INN ID

10724

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-17

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cnc2[C@H](CCCc2c1)N(Cc3[nH]c4c(n3)cccc4)CCCCN

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mavorixafor. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.